186 related articles for article (PubMed ID: 2366192)
21. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
Raeburn D; Karlsson JA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
[TBL] [Abstract][Full Text] [Related]
22. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
Heuer HO
Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
[TBL] [Abstract][Full Text] [Related]
23. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
[TBL] [Abstract][Full Text] [Related]
24. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
[TBL] [Abstract][Full Text] [Related]
25. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
26. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
[TBL] [Abstract][Full Text] [Related]
28. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
[TBL] [Abstract][Full Text] [Related]
29. Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs.
Inoue H; Aratani H; Takishima T; Kagoshima M; Iwahisa Y; Terasawa M
J Lipid Mediat; 1992; 5(2):173-6. PubMed ID: 1525360
[TBL] [Abstract][Full Text] [Related]
30. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
Borman RA; Jewell R; Hillier K
Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
34. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
Heuer HO
J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.
Turner NC; Wood LJ
J Pharmacol Exp Ther; 1992 Sep; 262(3):1139-46. PubMed ID: 1326625
[TBL] [Abstract][Full Text] [Related]
36. Effects of histamine, ethanol, and a detergent on exudation and absorption across guinea pig airway mucosa in vivo.
Greiff L; Erjefält I; Wollmer P; Pipkorn U; Persson CG
Thorax; 1991 Oct; 46(10):700-5. PubMed ID: 1721244
[TBL] [Abstract][Full Text] [Related]
37. Effect of platelet activating factor on formation and composition of airway fluid in the guinea-pig trachea.
Rogers DF; Alton EW; Aursudkij B; Boschetto P; Dewar A; Barnes PJ
J Physiol; 1990 Dec; 431():643-58. PubMed ID: 1712848
[TBL] [Abstract][Full Text] [Related]
38. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
Johnson PR; Armour CL; Black JL
Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
[TBL] [Abstract][Full Text] [Related]
39. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
Lu Z; Wolf MB
Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
[TBL] [Abstract][Full Text] [Related]
40. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
